Press release
Tendinopathy Pipeline and Clinical Trials Pipeline Analysis 2023 (Updated): 5+ Companies are working to improve the Treatment of Space | MiMedx, Hisamitsu Pharmaceuticals, Seikagaku Corporation
Tendinopathy Pipeline
In the Tendinopathy Pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, Tendinopathy NDA approvals (if any), and product development activities comprising the technology, Tendinopathy collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
To explore more information on the latest breakthroughs in the Tendinopathy pipeline treatment landscape of the report, click here @ Tendinopathy Pipeline Outlook- https://www.delveinsight.com/report-store/tendinopathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Tendinopathy Pipeline Report
• DelveInsight's Tendinopathy Pipeline analysis depicts a robust space with 5+ active players working to develop 5+ pipeline treatment therapies.
• The leading Tendinopathy Companies working in the market include MiMedx, Hisamitsu Pharmaceuticals, Seikagaku Corporation, MetrioPharm, Novartis, TRB Chemedica AG, ZARS Pharma Inc, Zimmer Biomet, Erasmus Medical Center, Merck Sharp & Dohme LLC, Biosplice Therapeutics Inc, Anika Therapeutics Inc, and others
• Promising Tendinopathy Pipeline Therapies in the various stages of development include NGI226, secukinumab, Tendoactive, etoricoxib, diclofenac, SM04755, Saline Injection, Corticosteroid, MRX-7EAT, Dexamethasone Iontophoretic Patch (low dose), and others.
• On July 2023, Novartis Pharmaceuticals announced a study of phase 2 clinical trials for NGI226. The purpose of this study is to measure local and systemic safety and tolerability as well as improvement of Achilles tendon mechanical properties after a single peritendon injection of NGI226 MP in comparison to placebo MP in patients with mid-portion Achilles Tendinopathy.
• On April 2023, Novartis Pharmaceuticals announced a study of phase 3 clinical trials for secukinumab. The purpose of this study is to investigate the efficacy and safety of AIN457 (secukinumab s.c.) compared to placebo in adult patients with moderate to severe rotator cuff Tendinopathy and failure to conventional therapy.
• On January 2023, University of Wisconsin, Madison announced a study of phase 2 clinical trials for PRP and Dry Needling. The overall goal of this research is to find an effective treatment for patellar tendinopathy (PT). To achieve this, we will conduct a double-blinded randomized controlled trial to investigate if platelet-rich plasma is effective for treatment. Clinical (pain and function scores) and bio-mechanical (knee strength) measures will be correlated with disease modification changes assessed using conventional and novel quantitative magnetic resonance imaging (MRI) and ultrasound (US) techniques.
Tendinopathy Overview
Tendinopathies are very common in general population and a huge number of tendon-related procedures take place annually worldwide, with significant socio-economic repercussions. Numerous treatment options are commonly used for tendon disorders.
To explore more information on the latest breakthroughs in the Tendinopathy Pipeline treatment landscape of the report, click here @ https://www.delveinsight.com/sample-request/tendinopathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Tendinopathy Emerging Drugs Profile
• dHACM: MiMedx
Tendinopathy Pipeline Therapeutics Assessment
There are approx. 5+ key companies which are developing the therapies Tendinopathy. The Tendinopathy companies which have their Tendinopathy drug candidates in the most advanced stage, i.e phase III include MiMedx.
Request a sample and discover the recent advances in Tendinopathy Ongoing Clinical Trial Analysis and Medications, click here @ https://www.delveinsight.com/sample-request/tendinopathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Tendinopathy Drugs and Companies
• NGI226: Novartis Pharmaceuticals
• Tendoactive: Bioiberica
• etoricoxib: Argentine Tennis Association
• diclofenac: Merck Sharp & Dohme LLC
• SM04755: Biosplice Therapeutics Inc
Tendinopathy Therapeutics Assessment
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
Some of the Companies in the Tendinopathy Therapeutics Market include-
MiMedx, Hisamitsu Pharmaceuticals, Seikagaku Corporation, MetrioPharm, Novartis, TRB Chemedica AG, ZARS Pharma Inc, Zimmer Biomet, Erasmus Medical Center, Merck Sharp & Dohme LLC, Biosplice Therapeutics Inc, Anika Therapeutics Inc, and others.
Dive deep into rich insights for drugs for Tendinopathy Pipeline, click here for Tendinopathy Unmet Needs and Analyst Views @ https://www.delveinsight.com/sample-request/tendinopathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Tendinopathy Pipeline Report
• Coverage- Global
• Tendinopathy Companies- MiMedx, Hisamitsu Pharmaceuticals, Seikagaku Corporation, MetrioPharm, Novartis, TRB Chemedica AG, ZARS Pharma Inc, Zimmer Biomet, Erasmus Medical Center, Merck Sharp & Dohme LLC, Biosplice Therapeutics Inc, Anika Therapeutics Inc, and others.
• Tendinopathy Pipeline Therapies- NGI226, secukinumab, Tendoactive, etoricoxib, diclofenac, SM04755, Saline Injection, Corticosteroid, MRX-7EAT, Dexamethasone Iontophoretic Patch (low dose), and others
• Tendinopathy Segmentation: Product Type, Molecule Type, Route of Administration
Got Queries? Find out the related information on Tendinopathy Mergers and acquisitions, Licensing Activities @ https://www.delveinsight.com/sample-request/tendinopathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Tendinopathy Executive Summary
3. Tendinopathy: Overview
4. Tendinopathy Pipeline Therapeutics
5. Tendinopathy Therapeutic Assessment
6. Tendinopathy- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. dHACM: MiMedx
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. SI-613: Seikagaku Corporation
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I/II)
14. Drug name: Company name
15. Drug profiles in the detailed report…..
16. Preclinical Stage Products
17. Drug name: Company name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Tendinopathy Key Companies
21. Tendinopathy Key Products
22. Tendinopathy- Unmet Needs
23. Tendinopathy- Market Drivers and Barriers
24. Tendinopathy- Future Perspectives and Conclusion
25. Tendinopathy Analyst Views
26. Tendinopathy Key Companies
27. Appendix
Important Published Links-
https://aeros.mn.co/posts/45751762
https://churecipe.mn.co/posts/45751826
https://itravel.mn.co/members/20248979
https://hubvin.mn.co/posts/45752020
https://drujrake.mn.co/posts/45752126
https://together.mn.co/posts/45752522
https://bipolarjungle.mn.co/posts/45752571
https://mossfon.mn.co/posts/45752666
https://create-lifestyle.mn.co/posts/45753329
https://gelardas.mn.co/members/20249381
https://bloby.mn.co/posts/45753578
https://cic-mun.mn.co/posts/45753710
https://www.exchangle.com/dennydones9
https://old.meneame.net/user/dennydones9
https://gsap.com/community/profile/159086-denny-dones/
https://www.pling.com/u/dennydones9/
https://shaunbook.mn.co/posts/type-1-diabetes-market-size-forecast-and-outlook-2032
https://zip-launchpad.mn.co/posts/45579349
https://dj-club-sf.mn.co/posts/45579415
https://wwwpreparatorianis.mn.co/posts/45579543
https://www.projectnoah.org/users/dennydones9
https://naijases.mn.co/posts/type-1-diabetes-market-future-trends-and-opportunities
https://indicate.mn.co/posts/45580238
https://linkasia.mn.co/posts/45580415
https://playhq.mn.co/posts/45580609
https://coco-quinn.mn.co/posts/45580757
https://www.storeboard.com/JohnSmith-5965202
https://doodleordie.com/profile/dennydones99
https://macro.market/company/delveinsight-business-research
https://pantip.com/profile/7306022#topics
https://allmylinks.com/dennydonesusa
https://uconnect.ae/read-blog/4382
https://blacksnetwork.net/post/102497_herpetic-keratitis-is-a-condition-that-affects-the-eye-and-is-caused-by-the-herp.html
https://ekonty.com/-dennydones99
https://app.wedonthavetime.org/posts/03e285b9-e449-4c96-b257-8cb7a2b74243
https://www.weddingbee.com/members/dennydones99/
https://community.storytellingwithdata.com/members/me/gallery
https://participer.valdemarne.fr/profiles/denny_dones/activity
https://elderassociation.mn.co/posts/45117025
https://www.domestika.org/en/dennydones99
https://nxgen.mn.co/members/19995548
https://www.laclt.com/profile/ybhardwaj/profile
https://stemfemmes.mn.co/posts/emerging-trends-in-managing-hot-flashes-in-the-prostate-cancer-market
https://network-91053.mn.co/posts/45119865
https://autism-support.mn.co/posts/understanding-hot-flashes-in-prostate-cancer-market-size-and-outlook-2032
https://jasa-seo.mn.co/posts/45120226
https://lapp.unl.edu.ec/profiles/dennydones99/activity?locale=en
https://imarticus.org/skillenza/user/dennydones9
https://oppathingzz.mn.co/members/20019648
https://findaspring.org/members/dennydones9/
https://www.poeticous.com/yashveer-bhardwaj
https://git.disroot.org/dennydones9
https://kuula.co/profile/havensmith
https://artmight.com/user/profile/3082810
https://www.credly.com/users/denny-dones/badges
https://quantum-buoyancy.mn.co/posts/axillary-hyperhidrosis-market-size-and-outlook-delveinsight
https://freeline.mn.co/posts/45202136
https://3dwarehouse.sketchup.com/user/0e9f9584-794e-4467-ac59-79db9efbadd9/Denny-Dones
https://www.hackster.io/dennydones9
https://letterboxd.com/dennydones9/
https://ko-fi.com/dennydones9
https://wakelet.com/@DennyDones813
https://onedio.com/profil/dennydones9
https://www.lyrics.com/user/349564/dennydones9#google_vignette
https://hypothes.is/users/dennydones9
https://shivambhu-hut.mn.co/posts/exploring-the-axillary-hyperhidrosis-market-innovations-treatments-and-future-prospects
https://zumvu.com/dennydones9/
https://onlyfans.com/dennydones9
https://maker.wiznet.io/dennydones9
https://collab.sundance.org/people/Denny-Dones-1699939772
https://insurtechasia.mn.co/posts/45403575
https://meganto-lottery.mn.co/posts/45403650
https://ylimun.mn.co/posts/45403740
https://network-79379.mn.co/posts/45404061
https://acatpg.mn.co/posts/45404422
https://brooklynneo.mn.co/posts/45404495
https://ucat-bootcamp.mn.co/posts/45404540
https://coding-playground.mn.co/posts/45404600
https://living-word-network.mn.co/posts/45404653
https://treadmill.mn.co/posts/45459156
https://chineseintheus.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast
https://wear.net/dennydones9/
https://productinn.mn.co/posts/parkinsons-disease-market-outlook-and-forecast-report-2032
https://justchatting.mn.co/posts/45460636
https://expressyourcurve.mn.co/posts/45460860
https://clinalleve.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast-2032
https://nhattao.com/members/user6331540.6331540/
https://seedly.sg/profile/denny-dones/
https://note.com/denny_dones/n/n489e5dd1ff1a
https://www.uplabs.com/dennydones9
https://www.zazzle.com/mbr/238605385879691977
https://independent.academia.edu/HavenSmith2
https://play.eslgaming.com/player/19736877/
https://creators.audiomack.com/dennydones1
https://piano.masto.host/@dennydones9
https://tech4goodwales.mn.co/posts/the-evolving-landscape-of-the-major-depressive-disorder-market
https://worldletinews.mn.co/members/20156129
https://community.greeka.com/users/dennydones9
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers and acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tendinopathy Pipeline and Clinical Trials Pipeline Analysis 2023 (Updated): 5+ Companies are working to improve the Treatment of Space | MiMedx, Hisamitsu Pharmaceuticals, Seikagaku Corporation here
News-ID: 3295296 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Tendinopathy
Tendinopathy Market Size, Share and Competitive Landscape
Tendinopathy refers to the condition where the tendons, which are the thick fibrous tissues that connect muscles to bones, become damaged or inflamed, leading to pain, swelling, and restricted movement. It is a common issue for athletes, manual laborers, and aging populations. The tendinopathy market is growing rapidly, driven by the rising incidence of sports injuries, increasing healthcare access, and advancements in treatments, including biologics, physical therapy, and surgical interventions.…
Tendinopathy Market is expected to reach US$ 299.16 billion by 2031- Zimmer Biom …
The Tendinopathy Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/tendinopathy-market
What is the projected growth…
Tendinopathy Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, E …
(Albany, USA) The Tendinopathy market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as MiMedx Group, Novartis Pharmaceuticals, Ipsen, Orthocell Limited, ZARS Pharma Inc., Zimmer Biomet, Causeway Therapeutics, Travanti Pharma Inc., Abbisko Therapeutics Co, Ltd, Deciphera Pharmaceuticals, LLC, Daiichi Sankyo, AmMax Bio, Inc., AmMax Bio, Inc.,
DelveInsight's "Tendinopathy Market Insights, Epidemiology, and Market Forecast 2034."…
Tendinopathy Market Forecasted for Substantial Growth (2024-2031) | Zimmer Biome …
The Tendinopathy Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Get a Free Sample PDF - https://datamintelligence.com/download-sample/tendinopathy-market
What is the projected growth rate (CAGR) of the Global Tendinopathy market from 2024…
Tendinopathy Market Sales and Revenue, Segments and Research Methodology by Fore …
DataM Intelligence has released a new research report on the Tendinopathy market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits, gross…
Tendinopathy Market Size is Set for Rapid Growth as Innovative Treatments and Ri …
The Tendinopathy market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as MiMedx Group, Novartis Pharmaceuticals, Ipsen, Orthocell Limited, ZARS Pharma Inc., Zimmer Biomet, Causeway Therapeutics, Travanti Pharma Inc., Abbisko Therapeutics Co, Ltd, Deciphera Pharmaceuticals, LLC, Daiichi Sankyo, AmMax Bio, Inc., AmMax Bio, Inc.,
[Nevada, United States] - DelveInsight's "Tendinopathy Market Insights, Epidemiology, and…
